SETT: The Sensing ET Tube

Sponsor
City, University of London (Other)
Overall Status
Completed
CT.gov ID
NCT03250065
Collaborator
Barts & The London NHS Trust (Other)
16
2
1
6.9
8
1.2

Study Details

Study Description

Brief Summary

This proposal describes the development of a 'Sensing ET Tube'. This device will replace the standard endotracheal (ET) tube used in anaesthesia and in ventilated intensive care patients and provide key vital signs monitoring utilising optoelectronic sensors. Continuous monitoring of patients' arterial oxygen saturation is essential during surgery, however pulse oximeters often misread or fail altogether as a result of peripheral vasoconstriction, hypotension or hypovolaemia. The Sensing ET Tube will allow continuous measurement of oxygen saturation and other parameters, such as pulse rate, from a single internal site, and will reduce the number of surface sensors placed on the skin and the number of electrical connections to the patient. The applicants have already developed similar sensor technology in the oesophagus and other internal locations. A pilot clinical evaluation of the device will be completed in anaesthetised patients undergoing surgery. The project will lead to further development of a multi-sensor tracheal platform for comprehensive anaesthesia and intensive care monitoring.

Condition or Disease Intervention/Treatment Phase
  • Device: Application of prototype sensor to a standard endotracheal tube
N/A

Detailed Description

The aim of this project is to develop and evaluate a novel medical device known as the 'Sensing ET Tube' for measuring oxygen levels in patients undergoing surgical operations. The device replaces the standard breathing tube used in surgery and incorporates photonic sensors for measurement of the patient's oxygen level and other vital signs. Currently this information is supplied from finger probes, which can fail often, for example when the patient is cold or when the blood pressure is low. The new device is completely harmless and allows the anaesthetist to monitor the oxygen level from the central region of the body using minimal connections. If successful, future work is planned to incorporate other sensors into the system, providing a complete overview of the health of the patient. This will greatly simplify the process of patient monitoring while reducing the number of failures, improving patient safety and reducing operating costs.

A clinical trial is planned in up to 50 patients undergoing general anaesthesia, which will quantitatively evaluate the accuracy and reliability of the measured clinical variables and the device's expected performance in mainstream operation. This information will provide the basis for further commercial development, most likely through partnership with a medical device manufacturer.

To summarise, the main aims of the project are:
  • Investigate photoplethysmographic signals from the human trachea and identify viability to measure heart rate, and blood oxygen saturation by comparison with "gold standard" techniques.

  • Evaluate custom-designed endotracheal sensor for operation and determine ideal electrical characteristics for optimal operation (current supply, detector amplification etc.)

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Development of the "Sensing Endotracheal Tube": an Optical Multi-parameter Monitoring System.
Actual Study Start Date :
Mar 3, 2017
Actual Primary Completion Date :
Jul 31, 2017
Actual Study Completion Date :
Sep 30, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: ETT Study Group

The Sensing ET Tube study Group

Device: Application of prototype sensor to a standard endotracheal tube
During anaesthesia the device under study, a prototype saturation sensor will be applied to a standard endotracheal tube that ventilates the patient as normal.

Outcome Measures

Primary Outcome Measures

  1. To validate the pulse oximetry signals from the trachea during anaesthesia for their suitability in determining vital signs, not limited to just oxygen saturation. [1 year]

    Raw optical electrical signals related to the absorbion of red and infrared light from the prototype sensor by the tissue in the trachea will be assessed for their viability to reliable determine pulse rate and oxygen saturation compared to the standard clinical devices during surgery. The signals will be further analysed to look for correlation with recorded blood pressure measurents and respiration rates.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ASA I-III

  • 18 Years and older

  • Undergoing elective surgery requiring general anaesthesia, and endotracheal tube as part of their anaesthetic.

Exclusion Criteria:
  • Those who refuse consent

  • Known or potentially difficult airway

  • Respiratory conditions including severe asthma, COPD, lung cancer etc.

  • Pregnant women

Contacts and Locations

Locations

Site City State Country Postal Code
1 City, University of London London United Kingdom EC1V0HB
2 Barts and The London NHS Trust London United Kingdom

Sponsors and Collaborators

  • City, University of London
  • Barts & The London NHS Trust

Investigators

  • Principal Investigator: Saowarat Snidvongs, MD, Barts and The London NHS Trust
  • Study Director: Justin Phillips, PhD, City, University of London
  • Study Chair: Panayiotis A Kyriacou, PhD, City, University of London

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
City, University of London
ClinicalTrials.gov Identifier:
NCT03250065
Other Study ID Numbers:
  • RCBE/2015/01
First Posted:
Aug 15, 2017
Last Update Posted:
Feb 12, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 12, 2018